由于可能无效,召回了140 000多瓶通用阿托尔瓦斯特丹,但没有报告严重伤害。 Over 140,000 bottles of generic Atorvastatin are recalled due to potential ineffectiveness, with no serious injuries reported.

Atorvastatin Calcium Patts(一种常见的胆固醇药物)有140,000多瓶普通的Atorvastatin Calcium Patts(Atorvastatin Calcium Patts),由于溶解测试失败而被召回,这可能会降低药效。 Over 140,000 bottles of generic Atorvastatin Calcium Tablets, a common cholesterol medication, are being recalled due to failed dissolution testing, which may reduce the drug’s effectiveness. 美国食品和药物管理局将其归类为II类,涉及90个,500个和1000个瓶子,其到期日期从2026年6月到2027年2月. The recall, classified as Class II by the FDA, involves 90-, 500-, and 1,000-count bottles with expiration dates from June 2026 to February 2027. 该药物由印度的Alkem实验室制造,由新泽西的Ascend实验室分发,是用于降低胆固醇和减少心脏病风险的Lipitor的通用版本。 Manufactured by Alkem Laboratories in India and distributed by Ascend Laboratories in New Jersey, the medication is a generic version of Lipitor used to lower cholesterol and reduce heart disease risk. 没有关于严重不良事件的报告,但林业发展局警告该药物可能不能如预期的那样起作用。 No serious adverse events have been reported, but the FDA warns the drug may not work as intended. 敦促消费者检查其批量号码,咨询保健提供者以寻求指导。 Consumers are urged to check their lot numbers and consult a healthcare provider for guidance.